Nanoparticle formation from probucol/PVP/sodium alkyl sulfate co-ground mixture

International Journal of Pharmaceutics

Volumn 376, Issue 1-2, 2009, Pages 169-175

  Wanawongthai, C ^a   Pongpeerapat, A ^a   Higashi, K ^a   Tozuka, Y ^b   Moribe, K ^a   Yamamoto, K ^a  

^a CHIBA UNIVERSITY   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Grinding; Nanoparticles; Polyvinylpyrrolidone; Probucol; Solid state NMR; Surfactants

Indexed keywords

ALKYL SULFATE SODIUM; ANIONIC SURFACTANT; DODECYL SULFATE SODIUM; NANOPARTICLE; OCTYL SULFATE SODIUM; POVIDONE; PROBUCOL; SODIUM HEXYL SULFATE; SODIUM OCTADECYL SULFATE; SURFACTANT; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; ELECTRICITY; GRINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR INTERACTION; NANOPHARMACEUTICS; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ALKANESULFONIC ACIDS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; NANOPARTICLES; PARTICLE SIZE; POVIDONE; PROBUCOL; SURFACE-ACTIVE AGENTS;

EID: 67349210622     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.04.034     Document Type: Article

References (30)

1. Amidon G.L., Lennernäs H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
2. Behn S. Sodium luaryl sulfate. In: Wade A., and Weller P.J. (Eds). Handbook of Pharmaceutical Excipients. 2nd Ed. (1994), Alden Multimedia, Northamton 448-450
3. Brewster M.E., and Loftsson T. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems. Pharmazie 57 (2002) 94-101
4. Brittain H.G. Effect of mechanical processing on phase composition. J. Pharm. Sci. 91 (2002) 1573-1580
5. Craig D.Q.M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231 (2002) 131-144
6. Hamada Y., Matsumoto H., Yamaguchi S., Kimura T., Hayashi Y., and Kiso Y. Water-soluble prodrugs of dipeptide HIV protease inhibitors based on O → N intramolecular acyl migration: design, synthesis and kinetic study. Bioorg. Med. Chem. 12 (2004) 159-170
7. Juhász Z. Aspect of mechanical activation in terms of comminution theory. Colloids Surf. A: Physicochem. Eng. Aspects 141 (1998) 449-462
8. Khan M.A., Karnachi A.A., Agarwal V., Vaithiyalingam S.R., Nazzal S., and Reddy I.K. Stability characterization of controlled release coprecipitates and solid dispersions. J. Control. Release 63 (2000) 1-6
9. Leuner C., and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50 (2000) 47-60
10. Mántylá A., Rautio J., Nevalainen T., Keski-Rahkonen P., Vepsälainen J., and Järvinen T. Design, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone. Eur. J. Pharm. Sci. 23 (2004) 151-158
11. Merisko-Liversidge E., Liversidge G.G., and Cooper E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18 (2003) 113-120
12. Moribe K., Pongpeerapat A., Tozuka Y., and Yamamoto K. Drug nanoparticle formation from drug/HPMC/SDS ternary ground mixture. Pharmazie 61 (2006) 97-101
13. Mura P., Cirri M., Faucci M.T., Ginès-Dorado J.M., and Bettinetti G.P. Investigation of effects of grinding and co-grinding on physicochemical properties of glisentide. J. Pharm. Biomed. Anal. 30 (2002) 227-237
14. Nielsen A.B., Frydenvang K., Liljefors T., Buur A., and Larsen C. Assessment of the combined approach of N-alkylation and salt formation to enhance aqueous solubility of tertiary amines using bupivacaine as a model drug. Eur. J. Pharm. Sci. 24 (2005) 85-93
15. Parrott E.L. Milling of pharmaceutical solids. J. Pharm. Sci. 63 (1974) 813-829
16. Pongpeerapat A., Higashi K., Tozuka Y., Moribe K., and Yamamoto K. Molecular interaction among Probucol/PVP/SDS multicomponent system investigated by solid-state NMR. Pharm. Res. 23 (2006) 2566-2574
17. Pongpeerapat A., Itoh K., Tozuka Y., Moribe K., Oguchi T., and Yamamoto K. Formation and stability of nanoparticles obtained from drug/PVP/SDS ternary ground mixture. J. Drug Sci. Tech. 14 (2004) 441-447
18. Pongpeerapat A., Wanawongthai C., Tozuka Y., Moribe K., and Ymamoto K. Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture. Int. J. Pharm. 352 (2008) 309-316
19. Saleki-Gerhardt A., Ahlneck C., and Zografi G. Assessment of disorder in crystalline solids. Int. J. Pharm. 101 (1994) 237-247
20. Shudo J., Pongpeerapat A., Wanawongthai C., Moribe K., and Yamamoto K. In vivo assessment of oral administration of probucol nanoparticles in rats. Biol. Pharm. Bull. 31 (2008) 321-325
21. Suzuki H., Ogawa M., Hironaka K., Ito K., and Sunada H. A nifedipine coground mixture with sodium deoxycholate. II. Dissolution characteristics and stability. Drug Dev. Ind. Pharm. 27 (2001) 951-958
22. Tadeschi A.M., Busi E., Basodi R., Paduano L., and D'Errico G. Influence of the alkyl tail length on the anionic surfactant-PVP interaction. J. Solut. Chem. 35 (2006) 951-968
23. Takagi T., Ramachandran C., Bermejo M., Yamashita S., Yu L.X., and Amidon G.L. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol. Pharm. 3 (2006) 31-643
24. Uekama K. Design and evaluation of cyclodextrin-based drug formulation. Chem. Pharm. Bull. 52 (2004) 900-915
25. Valizadeh H., Nokhodchi A., Qarakhani N., Zakeri-Milani P., Azarmi S., Hassanzadeh D., and Lobenberg R. Physicochemical characterization of solid dispersions of indomethacin with PEG, 6000 Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev. Ind. Pharm. 30 (2004) 303-317
26. Vergote G.J., Vervaet C., Driessche I.V., Hoste S., Smedt S.D., Demeester J., Jain R.A., Ruddy S., and Remon J.P. In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen. Int. J. Pharm. 240 (2002) 79-84
27. Walking W.D. Povidone. In: Wade A., and Weller P.J. (Eds). Handbook of Pharmaceutical Excipients. 2nd Ed. (1994), Alden Multimedia, Northamton 392-399
28. Yagi N., Terashima Y., Kenmotsu H., Sekikawa H., and Takada M. Dissolution behavior of probucol from solid dispersion systems of probucol-polyvinylpyrrolidone. Chem. Pharm. Bull. 44 (1996) 241-244
29. Zaitseva T.M., Lupanov V.P., Lyakishev A.A., Titov V.N., and Polevaya T.Y. Pharmacokinetics of probucol dosage forms in clinical tests. Pharm. Chem. J. 29 (1995) 245-247
30. Zu Y.G., Li Q.Y., Fu Y.J., and Wang W. Synthesis and cytotoxicity of water soluble quaternary salt derivatives of camptothecin. Bioorg. Med. Chem. Lett. 14 (2004) 4023-4026